Catheter Ablation › WPW · 2006–2026
Catheter Ablation (WPW)Results over 20 years, to 2026
Results of catheter ablation for WPW syndrome in our department over the 20 years from my arrival at Osaka City General Hospital in 2006 to 2026. Procedures, success and recurrence are shown by accessory pathway location (left, septal, right) and by period (three periods), together with the location by manifest, intermittent and concealed type, radiofrequency vs. cryoablation, and asymptomatic WPW. See also all ablation data.
Summary
Procedures
702
January 2006–September 2026, 643 patients
Overall success rate
98.6%
January 2006–September 2026, 692 of 702
Overall recurrence rate
10.8%
January 2006–September 2026, 76 of 702
Recurrence rate in 2019–2026
Left
3.3%
9.9% in 2006–2012
Septal
15.8%
23.4% in 2006–2012
Right
7.0%
21.0% in 2006–2012
All three sites
7.2%
19 of 264; 15.4% in 2006–2012
Success rate in 2019–2026
Left
98.3%
119 of 121
Septal
98.2%
56 of 57
Right
98.8%
85 of 86
All three sites
98.5%
260 of 264; 97.9% in 2006–2012
In 2019–2026 the recurrence rate was lower than in the two earlier periods at every site: left, septal and right.
Accessory pathway location (manifest, intermittent, concealed)
We divided WPW into three types by how the delta wave appears on the ECG and compared the proportions of accessory pathway locations (left, septal, right). Each patient is counted once (repeat procedures are not counted).
- Left45%165
- Septal21%79
- Right34%125
- Left40%39
- Septal22%21
- Right38%37
- Left68%126
- Septal17%32
- Right14%26
Success and recurrence by type
| Type | Procedures | Success (%) | Recurrence (%) |
|---|---|---|---|
| Manifest | 342 | 99.1 | 9.6 |
| Intermittent | 102 | 99.0 | 14.7 |
| Concealed | 194 | 97.4 | 10.8 |
Concealed pathways were rarely right-sided. I think this finding is not widely known.
When a patient had more than one accessory pathway, each location was counted once (so the location total is slightly larger than the number of patients). Among patients whose type was not recorded, those whose type could be determined from the description of the preprocedural ECG were included in that type; the 12 patients whose type could not be determined were excluded. Our paper on 1,021 ablation procedures (2006–2018) showed the same tendency (see the paper).
Recurrence rate by location and period
- 2006–2012
- 2013–2018
- 2019–2026
Recurrence rate (%)
Radiofrequency and cryoablation
Accessory pathways are usually treated by burning with radiofrequency (RF). Since 2016, for septal pathways right next to the AV node (the electrical pathway of the heart) and in similar situations, we have also used cryoablation, which treats by freezing. The breakdown of 702 procedures:
- Radiofrequency92%649
- Cryo6%44
- Both1%9
- Radiofrequency
- Cryo
- Both
- 2006–2012
- 2013–2018
- 2019–2026
| Energy | Procedures | Success (%) | Recurrence (%) |
|---|---|---|---|
| Radiofrequency (RF) | 649 | 98.6 | 10.2 |
| Cryo | 44 | 100.0 | 20.5 |
| Both | 9 | 88.9 | 11.1 |
"Both" means radiofrequency and cryo were both used in one procedure. Of the 44 procedures with cryo alone, 32 were for septal pathways (others: 10 right, 2 with no location recorded). Because the treated sites differ, success and recurrence rates cannot be compared directly.
Asymptomatic WPW
101 procedures were performed in patients whose delta wave was found by school heart screening or similar and who had no tachycardia (no symptoms). Without retrograde conduction from the ventricle to the atrium over the accessory pathway (AP-VA), the usual WPW tachycardia (atrioventricular reentrant tachycardia) does not occur.
Asymptomatic WPW
101
101 successful, 9 recurrences
No AP-VA
27
27% of 101
AP-VA present
74
73% of 101
AP-VA by location
- No AP-VA
- AP-VA present
- Left
- Septal
- Right
| Pathway location | Cases | No AP-VA | AP-VA present | No AP-VA (%) |
|---|---|---|---|---|
| Left | 44 | 12 | 32 | 27 |
| Septal | 25 | 6 | 19 | 24 |
| Right | 34 | 9 | 25 | 26 |
The 101 cases are procedure records (98 patients; 3 were treated twice). The 2 cases with two or more pathways are counted at each location, so the location total is slightly larger than 101. AP-VA was determined from the "WPW with AP_VA" / "WPW without AP_VA" fields in the procedure records; when these were blank, from the record of VA conduction (via the accessory pathway) in the electrophysiology study.
Tables
Procedures
| WPW location | 2006–2012 | 2013–2018 | 2019–2026 | Total |
|---|---|---|---|---|
| Left | 131 | 106 | 121 | 358 |
| Septal | 47 | 46 | 57 | 150 |
| Right | 62 | 71 | 86 | 219 |
| All* | 240 | 223 | 264 | 727 |
Recurrences
| WPW location | 2006–2012 | 2013–2018 | 2019–2026 | Total |
|---|---|---|---|---|
| Left | 13 | 9 | 4 | 26 |
| Septal | 11 | 8 | 9 | 28 |
| Right | 13 | 11 | 6 | 30 |
| All* | 37 | 28 | 19 | 84 |
Recurrence rate (%)
| WPW location | 2006–2012 | 2013–2018 | 2019–2026 | All periods |
|---|---|---|---|---|
| Left | 9.9 | 8.5 | 3.3 | 7.3 |
| Septal | 23.4 | 17.4 | 15.8 | 18.7 |
| Right | 21.0 | 15.5 | 7.0 | 13.7 |
| All* | 15.4 | 12.6 | 7.2 | 11.6 |
Successful procedures
| WPW location | 2006–2012 | 2013–2018 | 2019–2026 | Total |
|---|---|---|---|---|
| Left | 128 | 105 | 119 | 352 |
| Septal | 46 | 46 | 56 | 148 |
| Right | 61 | 71 | 85 | 217 |
| All* | 235 | 222 | 260 | 717 |
Success rate (%)
| WPW location | 2006–2012 | 2013–2018 | 2019–2026 | All periods |
|---|---|---|---|---|
| Left | 97.7 | 99.1 | 98.3 | 98.3 |
| Septal | 97.9 | 100.0 | 98.2 | 98.7 |
| Right | 98.4 | 100.0 | 98.8 | 99.1 |
| All* | 97.9 | 99.6 | 98.5 | 98.6 |
* The "All" row is the sum of left, septal and right (success and recurrence rates = successes or recurrences ÷ procedures). Procedures with more than one pathway are counted at each location, so "All" is slightly larger than the number of procedures (702).
Methods: from our department's ablation database, we counted all 702 procedures (643 patients) treated as WPW between January 1, 2006 and September 26, 2026. Repeat procedures in the same patient were each counted as one procedure. Success means that conduction over the accessory pathway was eliminated at the end of the procedure, or that symptoms improved. Recurrence is the number recorded as recurrence in the database (the length of follow-up was not standardized).
